tirzepatide for osa the Treatment of Obstructive Sleep Apnea and Obesity Tirzepatide and Semaglutide: Impact on

And a large dinner leads to nighttime nausea, reflux, and poor sleep

GLP-1 Pathway Shared with Ozempic Reduces appetite via hypothalamic signaling Slows gastric emptying (delays food leaving stomach) Stimulates glucose-dependent insulin secretion Suppresses glucagon release (reduces liver glucose output) Improves satiety and reduces food intake GIP Pathway Unique to Mounjaro Enhances insulin sensitivity in adipose tissue Improves fat metabolism and lipid handling Reduces fat storage in visceral depots Boosts energy expenditure (thermogenesis) Synergizes with GLP-1 for amplified weight loss Combined Effects on the Body Clinical Evidence SURMOUNT Clinical Trial Results Tirzepatide has the strongest evidence base of any weight loss medication ever studied

Niwa, M

In the cohorts we adjusted for age, sex, marital status, education, physical and psychiatric comorbidity registered within 10 years before the index date